Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

July 31, 2000

Study Completion Date

March 31, 2003

Conditions
Non-Hodgkin LymphomaHodgkin DiseaseThrombocytopenia
Interventions
DRUG

(PN-152,243)/ PN-196,444

Trial Locations (38)

3002

Pfizer Investigational Site, East Melbourne

11235

Pfizer Investigational Site, Brooklyn

17033

Pfizer Investigational Site, Hershey

24210

Pfizer Investigational Site, Abingdon

24211

Pfizer Investigational Site, Abingdon

24266

Pfizer Investigational Site, Lebanon

24354

Pfizer Investigational Site, Marion

27705

Pfizer Investigational Site, Durham

33321

Pfizer Investigational Site, Tamarac

37044

Pfizer Investigational Site, Tours

37620

Pfizer Investigational Site, Bristol

48076

Pfizer Investigational Site, Southfield

48202

Pfizer Investigational Site, Detroit

49085

Pfizer Investigational Site, Saint Joseph

60637

Pfizer Investigational Site, Chicago

60640

Pfizer Investigational Site, Chicago

65109

Pfizer Investigational Site, Jefferson City

68198

Pfizer Investigational Site, Omaha

70601

Pfizer Investigational Site, Lake Charles

85023

Pfizer Investigational Site, Phoenix

90036

Pfizer Investigational Site, Los Angeles

90048

Pfizer Investigational Site, Los Angeles

Pfizer Investigational Site, Jefferson City

90089

Pfizer Investigational Site, Los Angeles

92037

Pfizer Investigational Site, La Jolla

92354

Pfizer Investigational Site, Loma Linda

92868

Pfizer Investigational Site, Orange

97420

Pfizer Investigational Site, Coos Bay

115478

Pfizer Investigational Site, Moscow

125167

Pfizer Investigational Site, Moscow

169608

Pfizer Investigational Site, Singapore

169610

Pfizer Investigational Site, Singapore

90033-0804

Pfizer Investigational Site, Los Angeles

Unknown

Pfizer Investigational Site, Paris

Pfizer Investigational Site, Shatin

Pfizer Investigational Site, Warsaw

540 07

Pfizer Investigational Site, Thessaloniki

93-510

Pfizer Investigational Site, Lodz

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY